Trump says first US vaccine will be administered 'in less than 24 hours' | Inquirer News

Trump says first US vaccine will be administered ‘in less than 24 hours’

/ 11:30 AM December 12, 2020

WASHINGTON – President Donald Trump said the US will start administering the Pfizer-BioNTech Covid-19 vaccine “in less than 24 hours,” after the Food and Drug Adminstration granted it an emergency use authorization late Friday.

“The first vaccine will be administered in less than 24 hours,” Trump said in a televised address released on Twitter.

“Through our partnership with FedEx and UPS, we have already begun shipping the vaccine to every state and zip code in the country,” he said, adding that governors would decide who would receive the shots first in their states.

pfizer vaccine covid-19 biontech

In this illustration file photo taken on November 23, 2020 showing a bottle reading “Vaccine COVID-19” and a syringe next to the Pfizer and BioNtech logos. – An expert committee convened by the US Food and Drug Administration on December 10, 2020, voted heavily in favor of recommending the Pfizer-BioNTech Covid-19 vaccine for emergency use approval. (Photo by JOEL SAGET / AFP)

“We want our senior citizens, health care workers and first responders to be first in line,” said Trump. “This will quickly and dramatically reduce deaths and hospitalizations.”

gsg
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Pfizer, Trump, vaccine

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.